Cargando…
Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients
Seasonal influenza viruses cause annual disease epidemics that affect individuals at low and high risk for secondary illnesses. Influenza vaccines are widely used in high-risk patients to prevent infection, but the protection afforded varies by population; uptake is also limited in some groups. Anti...
Autor principal: | Dutkowski, Regina |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835508/ https://www.ncbi.nlm.nih.gov/pubmed/20215131 http://dx.doi.org/10.1093/jac/dkq012 |
Ejemplares similares
-
Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience
por: Smith, James R., et al.
Publicado: (2011) -
Safety and tolerability of a 6‐week course of oseltamivir prophylaxis for seasonal influenza in children
por: Reisinger, Keith, et al.
Publicado: (2012) -
Foreword: Oseltamivir for seasonal, avian and pandemic influenza: 10 years of clinical experience
por: Nguyen-Van-Tam, Jonathan S.
Publicado: (2010) -
Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
por: Hurt, Aeron C., et al.
Publicado: (2016) -
Oseltamivir Treatment for Influenza During the Flu Season of 2018–2019: A Longitudinal Study
por: Li, Xiao-Guang, et al.
Publicado: (2022)